This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Wall Street Analysts Believe Lemonade (LMND) Could Rally 40.28%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 40.3% in Lemonade (LMND). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Lemonade (LMND) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Lemonade (LMND) Q4 results reflect higher gross earned premiums, driven by an increase in in-force premium earned, which was offset by higher expense.
Lemonade (LMND) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of 20.51% and 12.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Assurant (AIZ) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Assurant (AIZ) delivered earnings and revenue surprises of 24.71% and 1.25%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Lemonade (LMND): Can Its 12.8% Jump Turn into More Strength?
by Zacks Equity Research
Lemonade (LMND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Kemper (KMPR) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Kemper (KMPR) delivered earnings and revenue surprises of 18% and 1.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Should You Retain Lemonade (LMND) Stock in Your Portfolio?
by Zacks Equity Research
Lemonade (LMND) is poised to gain from growth on premium placed with third-party insurance companies , interest rates on investment balances and growth in the average policy value.
Lemonade (LMND) Q3 Earnings Lag, Revenues Top, View Revised
by Zacks Equity Research
Lemonade (LMND) Q3 results reflect higher gross earned premiums, driven by an increase in in-force premium earned but offset by higher expense.
Lemonade (LMND) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of -0.74% and 13.54%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Trean Insurance (TIG) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Trean Insurance (TIG) delivered earnings and revenue surprises of 22.22% and 11.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Enact Holdings, Inc. (ACT) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Enact Holdings, Inc. (ACT) delivered earnings and revenue surprises of 31.46% and 0.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Lemonade (LMND) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Lemonade (LMND) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Add Radian Group (RDN) to Your Portfolio
by Zacks Equity Research
Improving mortgage insurance portfolio, declining claims, the well-performing homegenius segment and solid capital position poise Radian Group (RDN) well for growth.
Lemonade (LMND) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Lemonade (LMND) closed at $21.19 in the latest trading session, marking a +0.81% move from the prior day.
Lemonade (LMND) Stock Moves -1.28%: What You Should Know
by Zacks Equity Research
Lemonade (LMND) closed at $21.66 in the latest trading session, marking a -1.28% move from the prior day.
Reasons Why Lemonade (LMND) Stock is an Attractive Pick
by Zacks Equity Research
Lemonade (LMND) is poised to gain from higher net added customers, interest rates on investment balances and growth in premiums placed with third-party insurance companies.
Lemonade (LMND) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Lemonade (LMND) Q2 results reflect improved gross earned premiums, driven by an increase in-force premium earned, which was offset by higher expense.
Lemonade (LMND) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of 19.12% and 5.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Take-Two Interactive Software, Ionis Pharmaceuticals, Celsius Holdings, Grocery Outlet Holding and Lemonade
by Zacks Equity Research
Take-Two Interactive Software, Ionis Pharmaceuticals, Celsius Holdings, Grocery Outlet Holding and Lemonade are part of Zacks top Analyst Blog.
Cogent (CCOI) Q2 Earnings Beat Estimates, Revenues Lag
by Zacks Equity Research
Cogent Communications (CCOI) beats second-quarter earnings estimates due to the positive impact of foreign exchange rates
Cambium (CMBM) Q2 Earnings Beat Estimates, Revenues Lag
by Zacks Equity Research
Cambium (CMBM) beats second-quarter earnings estimates despite soft revenues due to sluggishness from service providers.
Coinbase (COIN) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Coinbase's (COIN) Q2 earnings are likely to benefit from increased adoption of a greater number of crypto assets and higher volatility coupled with a rise in interest across the entire crypto-economy.
Universal Display (OLED) Misses on Q2 Earnings and Revenues
by Zacks Equity Research
Universal Display (OLED) misses second-quarter earnings and revenue estimates due to headwinds weighing on consumer spending.
5 Stocks to Buy Ahead of Earnings Results Next Week
by Nalak Das
Five companies are slated to beat earnings estimates next week. These are: TTWO, IONS, CELH, LMND and GO.
Qorvo (QRVO) Q1 Earnings and Revenues Outpace Estimates
by Zacks Equity Research
Qorvo (QRVO) beats fiscal first-quarter earnings and revenue estimates due to strong growth across cellular applications.